Cardiff Oncology, Inc.
CRDF
$1.53
$0.032.00%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 46.06M | 58.30M | 60.59M | 70.96M | 79.89M |
| Total Receivables | 191.00K | 482.00K | 254.00K | 526.00K | 405.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.10M | 1.34M | 956.00K | 2.21M | 2.42M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 47.34M | 60.13M | 61.80M | 73.70M | 82.71M |
|
|
|||||
| Total Current Assets | 47.34M | 60.13M | 61.80M | 73.70M | 82.71M |
| Net Property, Plant & Equipment | 986.00K | 1.21M | 1.43M | 1.64M | 1.84M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 844.00K | 549.00K | 549.00K | 401.00K | 257.00K |
| Total Assets | 49.17M | 61.88M | 63.78M | 75.74M | 84.81M |
|
|
|||||
| Total Accounts Payable | 5.48M | 8.09M | 2.44M | 6.01M | 3.63M |
| Total Accrued Expenses | 8.34M | 6.83M | 11.54M | 9.94M | 8.04M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 646.00K | 730.00K | 726.00K | 721.00K | 716.00K |
| Total Finance Division Other Current Liabilities | -- | 744.00K | -- | -- | 902.00K |
| Total Other Current Liabilities | -- | 744.00K | -- | -- | 902.00K |
| Total Current Liabilities | 14.46M | 16.39M | 14.71M | 16.67M | 13.29M |
|
|
|||||
| Total Current Liabilities | 14.46M | 16.39M | 14.71M | 16.67M | 13.29M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 102.00K | 284.00K | 464.00K | 640.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 14.46M | 16.50M | 14.99M | 17.13M | 13.93M |
|
|
|||||
| Common Stock & APIC | 477.13M | 475.37M | 471.55M | 470.15M | 468.46M |
| Retained Earnings | -442.38M | -430.03M | -422.81M | -411.56M | -397.61M |
| Treasury Stock & Other | -49.00K | 50.00K | 50.00K | 17.00K | 27.00K |
| Total Common Equity | 34.71M | 45.39M | 48.79M | 58.61M | 70.88M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 34.71M | 45.39M | 48.79M | 58.61M | 70.88M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 34.71M | 45.39M | 48.79M | 58.61M | 70.88M |
|
|
|||||